GC Green Cross begins consignment production of the Corona 19 vaccine for Modena, an American pharmaceutical company.
As a domestic company takes over the consignment production of the corona vaccine (CMO), it will not only serve as a global production base for corona vaccine, but also will facilitate domestic distribution and distribution in the future.
According to the government on the 31st, “I know that Modena has chosen GC Green Cross as the consignment production partner for the corona vaccine.” The contract for 20 million people is currently underway by the Korea Centers for Disease Control and Prevention, and has not been finalized.
Bancell CEO said, “Even if a new virus emerges, it will be much shorter than when developing a corona vaccine if we cooperate with Korea.” You will be able to build it,” he said.
As GC Green Cross decided to take over the consignment production of modders or vaccines, domestic companies will leap to a global production base for producing corona vaccines.
SK Bioscience signed a consignment production contract with AstraZeneca in August and is currently supplying clinical trial products. The company has also signed a consignment development and production contract with NovaVax, another vaccine company, and the Korean government is currently negotiating with NovaVax to supply vaccines.